Hence, a hypothesis emerged that p38 MAPKIs might slow down the progression of the disease and improve the prognosis of patients with COPD by suppressing inflammation (Banerjee et al., 2012; Norman, 2015). This evidence concerns the gene MAPK1 and chronic obstructive pulmonary disease.